India Pesticides cash flow

Latest FY26

Cash from operations: ₹61.5cr+2,146.0% on FY25
Capital spending: ₹91.4cr+42.4% on FY25
Free cash flow: −₹29.8cr−₹61.4 cr in FY25
Cash from financing: ₹36.2cr+88.5% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	21.3	18.2	15.1	11.1
	—	5.7	0.0	0.0	0.0
	—	−6.7	−8.4	0.0	0.0
	—	−0.1	−0.7	−1.9	−0.3
	—	−2.2	−1.3	−0.4	−0.7
	—	0.2	0.0	0.0	1.4
	—	2.4	2.1	−0.0	−0.0
	—	−45.3	−34.6	16.9	−85.3
	—	−14.9	−107	22.8	−14.6
	—	0.1	3.4	6.7	−36.5
	—	0.2	0.0	0.0	0.0
	—	−48.3	1.5	−6.2	20.3
	—	0.0	5.9	−4.7	−0.3
	—	18.5	26.6	−2.5	8.7
	—	4.4	−0.5	7.1	−3.8
	—	0.1	3.6	3.5	−2.4
	—	0.4	2.2	1.3	1.5
Cash from operating activities
	150	166	111	82.3	192
	—	−64.1	−89.4	58.2	−101
	—	102	22.0	141	90.6
	—	0.0	0.0	−9.4	−4.2
	—	−0.3	−4.0	−4.1	−6.2
	—	40.6	23.2	21.2	47.2
	—	61.5	2.7	114	45.4
Cash from investing activities
	—	91.4	64.2	77.1	76.0
	—	0.1	0.1	0.3	0.2
	—	0.0	0.0	12.6	6.3
	—	5.5	0.0	14.3	11.7
	—	8.9	7.1	0.0	0.0
	—	4.9	4.8	0.0	0.0
	—	0.5	0.0	0.0	0.0
	—	6.6	8.5	9.4	4.2
	—	0.0	58.5	−53.9	42.0
	—	−82.8	0.7	−120	−24.3
Cash from financing activities
	—	0.0	0.0	0.5	0.0
	—	56.4	33.7	14.8	0.0
	—	1.1	0.4	0.0	10.8
	—	4.6	1.7	0.0	0.0
	—	5.9	3.7	3.4	5.4
	—	8.6	8.6	8.6	8.6
	—	0.0	−0.0	0.0	0.0
	—	36.2	19.2	3.3	−24.8
	—	14.9	22.6	−2.2	−3.7
	—	14.9	22.6	−2.2	−3.7
	—	—	—	10.4	12.6
Reference items
	164	174	120	86.6	197
	15.8%	16.4%	14.4%	12.7%	22.3%
	−29.8	−29.8	−61.4	36.9	−30.6
	—	19.5	−31.9	48.4	—
	−₹2.59	−₹2.59	−₹5.33	₹3.20	−₹2.66
	—	0.51×	0.03×	1.90×	0.32×
	—	40.6	23.2	21.2	47.2
	—	5.9	3.7	3.4	5.4

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

IPL₹116.50

India Pesticides Limited

· Chemicals

₹ CrorePeersMOL INSECTICID PUNJABCHEM ASTEC BHARATRAS DHARMAJ GSPCROP ADVANCEMcap ₹1,342 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	11.1	15.1	18.2	21.3	—
+ Finance Costs	0.0	0.0	0.0	5.7	—
+ Interest Income	0.0	0.0	-8.4	-6.7	—
+ Fair Value (Gains) / Losses	-0.3	-1.9	-0.7	-0.1	—
+ Unrealised FX (Gain) / Loss	-0.7	-0.4	-1.3	-2.2	—
+ Other Non-cash Items	1.4	0.0	0.0	0.2	—
+ Other Reconciling Items	-0.0	-0.0	2.1	2.4	—
Changes in Working Capital
+ Inventories	-85.3	16.9	-34.6	-45.3	—
+ Trade Receivables — Current	-14.6	22.8	-107.4	-14.9	—
+ Other Financial Assets — Current	-36.5	6.7	3.4	0.1	—
+ Other Financial Assets — Non-current	0.0	0.0	0.0	0.2	—
+ Other Current Assets	20.3	-6.2	1.5	-48.3	—
+ Other Non-current Assets	-0.3	-4.7	5.9	0.0	—
+ Trade Payables — Current	8.7	-2.5	26.6	18.5	—
+ Other Financial Liabilities — Current	-3.8	7.1	-0.5	4.4	—
+ Other Current Liabilities	-2.4	3.5	3.6	0.1	—
+ Provisions — Current	1.5	1.3	2.2	0.4	—
Cash from Operating Activities
Profit Before Tax (per I/S)	191.6	82.3	111.4	165.9	149.6
+ Total Adjustments (incl. Working Capital)	-101.0	58.2	-89.4	-64.1	—
Cash from Operations (pre-tax)	90.6	140.5	22.0	101.8	—
+ Interest Received — Operating	-4.2	-9.4	0.0	0.0	—
+ Interest Paid — Operating	-6.2	-4.1	-4.0	-0.3	—
+ Income Taxes Paid	47.2	21.2	23.2	40.6	—
Cash from Operating Activities	45.4	114.0	2.7	61.5	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	76.0	77.1	64.2	91.4	—
+ Disp of Fixed Assets	0.2	0.3	0.1	0.1	—
+ Acq of Investment Property	6.3	12.6	0.0	0.0	—
+ Disp of Investment Property	11.7	14.3	0.0	5.5	—
+ Acq of Other Long-term Assets	0.0	0.0	7.1	8.9	—
+ Disp of Other Long-term Assets	0.0	0.0	4.8	4.9	—
+ Disp of Subsidiaries / Businesses (net)	0.0	0.0	0.0	0.5	—
+ Interest Received — Investing	4.2	9.4	8.5	6.6	—
+ Other Inflows / (Outflows) — Investing	42.0	-53.9	58.5	0.0	—
Cash from Investing Activities	-24.3	-119.6	0.7	-82.8	—
Cash from Financing Activities
+ Proceeds from Other Equity Instruments	0.0	0.5	0.0	0.0	—
+ Proceeds from Borrowings	0.0	14.8	33.7	56.4	—
+ Repayment of Borrowings	10.8	0.0	0.4	1.1	—
+ Payment of Lease Liabilities	0.0	0.0	1.7	4.6	—
+ Interest Paid	5.4	3.4	3.7	5.9	—
+ Dividends Paid	8.6	8.6	8.6	8.6	—
+ Other Inflows / (Outflows) — Financing	0.0	0.0	-0.0	0.0	—
Cash from Financing Activities	-24.8	3.3	19.2	36.2	—
Net Changes in Cash (pre-FX)	-3.7	-2.2	22.6	14.9	—
Net Changes in Cash	-3.7	-2.2	22.6	14.9	—
Closing Cash	12.6	10.4	—	—	—
Reference Items
EBITDA	196.9	86.6	119.6	173.5	163.8
EBITDA Margin %	22.25	12.73	14.43	16.41	15.84
Free Cash Flow (CFO − Capex)	-30.6	36.9	-61.4	-29.8	-29.8
Free Cash Flow to Equity	—	48.4	-31.9	19.5	—
Free Cash Flow per Basic Share	-2.66	3.20	-5.33	-2.59	-2.59
Cash Flow to Net Income	0.32	1.90	0.03	0.51	—
Cash Paid for Taxes	47.2	21.2	23.2	40.6	—
Cash Paid for Interest	5.4	3.4	3.7	5.9	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.